首页 | 本学科首页   官方微博 | 高级检索  
     

固本益肠汤四联续贯疗法治疗脾虚泄泻疗效观察
引用本文:林一帆,李昊燃,王军,邹蕾,王长洪,陈山泉,陆宇平,杨卓,高文艳,巩阳,刘阳,王立新. 固本益肠汤四联续贯疗法治疗脾虚泄泻疗效观察[J]. 中国中西医结合消化杂志, 2008, 16(1): 29-31
作者姓名:林一帆  李昊燃  王军  邹蕾  王长洪  陈山泉  陆宇平  杨卓  高文艳  巩阳  刘阳  王立新
作者单位:沈阳军区总医院,中医科,国家中西医结合消化病重点专科,辽宁,沈阳,110015
摘    要:[目的]观察固本益肠汤联合甲硝唑、肠道益生菌及食物日志指导的饮食调整四联续贯疗法治疗脾虚泄泻的疗效。[方法]108例脾虚泄泻患者随机分为3组,四联治疗(A)组36例,给予固本益肠汤100ml/次,3次/d,联合甲硝唑200mg,2次/d,整肠生0.5g,3次/d及食物日志指导的饮食调整四联续贯治疗;对照1(B1)组36例,给予甲硝唑、整肠生;对照2(B2)组36例,仅给予甲硝唑,治疗剂量及方法均同A组;以上药物除甲硝唑服用1周外,其他服用至第4周,整肠生在甲硝唑停药后开始服用。所有病例均经结肠镜检查排除器质性疾病。[结果]A组治愈率(77.8%)明显优于B1、B2组(41.7%、13.9%)(P〈0.01),而B1组显效率(74.3%)较132组(30.6%)为优(P〈0.01)。停药后A组6周与12周复发率(8.3%、11.1%)均较B1、B2组(25.8%、42.9%,36.0%、52.0%)低(P〈0.01),B1、B2组12周复发率明显高于6周(P〈0.05)。[结论]固本益肠汤四联续贯疗法治疗脾虚泄泻,可提高治愈率及显效率,降低复发率,较单纯甲硝唑及甲硝唑与肠道益生菌联合治疗为优,临床观察无明显不良反应,是一种较有效的治疗方法。

关 键 词:脾虚泄泻  固本益肠汤  四联治疗
文章编号:1671-038X(2008)01-0029-03
收稿时间:2007-10-21
修稿时间:2007-10-21

Clinical value of Guben Yichang decoction based quadruple therapy in patient with diarrhea due to splenic asthenia
LIN Yi-fan,LI Hao-ran,WANG Jun,ZHOU Lei,WANG Chnag-hong,CHEN Shah-quan,LU Yu-ping,YANG Zuo,GAO Wen-yan,GONG Yang,LIU Yang,WANG Li-xin. Clinical value of Guben Yichang decoction based quadruple therapy in patient with diarrhea due to splenic asthenia[J]. Chinese Journal of Integrated Traditional and Western Medicine on Digestion, 2008, 16(1): 29-31
Authors:LIN Yi-fan  LI Hao-ran  WANG Jun  ZHOU Lei  WANG Chnag-hong  CHEN Shah-quan  LU Yu-ping  YANG Zuo  GAO Wen-yan  GONG Yang  LIU Yang  WANG Li-xin
Affiliation:LINYi-fan, LI Hao-ran, WANG Jun, ZHOU Lei, WANG Chang-hong , CHEN Shan-quan, LU Yu-ping , YANG Zuo, GAO Wen-yan, GONG Yang , LIU Yang , WANG Li-xin (Department of Traditional Chinese Medicine and Gastroenterology, Hospital of Shenyang Military District, Shenyang 110015 ,China)
Abstract:[Objective]To observe the curative effect of Guben Yichang decoction based quadruple therapy in patient with diarrhea due to splenic asthenia. [Methods]One hundred and eight cases of patients with diarrhea due to splenic asthenia were randomly divided into three groups, group A (n=36) received Guben Yichang decoction based quadruple therapy (Guben Yichang decoction 100ml,bid+Metronidazole 200mg bid+ Entrocoordinatibiogen 2 tablets bid+food-remedy ); group B1 (n=36) received double therapy (Metronidazole 200mg bid+ Entrocoordinatibiogen 2 tablets bid) ; group B2 received Metronidazole 200mg bid only. Metronidazole was given for one week, the others were four weeks; Entrocoordinatibiogen was given after Metronidazole. The diagnosis was determined by electronic colonoscopy. [Results] The curative rate in A (77. 8%) was better than that in B1/2(41. 7%, 13. 9%)(P〈0. 01). The excellence rate in B1(74. 3%) was better than that in B2(30.6%) (P〈0. 01). The recrudescence rate after stopping therapy 6w and 12w in A (8. 3%, 11.1%)were lower than that in B1/2 (25.8 %, 42. 9 % ; 36. 0%, 52.0%) (P〈0.01). The recrudescence rate of 12w in B1/2 were higher than that of 6w(P〈0. 01). [Conclusion]Guben Yichang decoction Based quadruple therapy in patient with diarrhea due to splenic asthenia could raise the curative rate and excellence rate, cut down recrudescence rate, which is better than that of antibiotic with probiotics or antibiotic only.
Keywords:diarrhea due to splenic asthenia   Guben Yichang decoction   quadruple therapy
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号